MALT lymphoma medical therapy: Difference between revisions
Varun Kumar (talk | contribs) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{MALT lymphoma}} | {{MALT lymphoma}} | ||
{{CMG}} | {{CMG}} | ||
| Line 18: | Line 20: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Needs content]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
Revision as of 20:01, 11 September 2012
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
|
MALT lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
MALT lymphoma medical therapy On the Web |
|
American Roentgen Ray Society Images of MALT lymphoma medical therapy |
|
Risk calculators and risk factors for MALT lymphoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical therapy
If the disease is limited to the stomach (which is assessed with computed tomography), then 70-80% of patients will have a complete regression on treatment with antibiotic eradication of H. pylori. [1]
Radiotherapy
Others may be effectively controlled with the use of radiotherapy, or surgery. Both modalities may be curative in localized disease.
Chemotherapy
In contrast, if the disease has spread or has been refractory on antibiotics, chemotherapy may need to be considered.
References
- ↑ Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M (1995). "Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group". Lancet. 345 (8965): 1591–4. PMID 7783535.